$DAVA

Here is Why Endava (DAVA) is One of the Underperforming Tech Stocks to Buy According to Analysts

Endava (NYSE:DAVA) reported FQ3 2026 revenue of £178.5 million, down 8.4% year over year, citing uneven demand and longer deal cycles. The company recorded a £364.6 million goodwill impairment and related tax charges, resulting in a diluted loss per share of £7.55. For FQ4, it expects revenue of £181.0–£185.0 million and adjusted diluted EPS of £0.09–£0.13.

Original reporting
Published Jun 27, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 27, 2026, 6:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here is Why Endava (DAVA) is One of the Underperforming Tech Stocks to Buy According to Analysts — source image
Decision brief

The 30-second read

$DAVABearishMed
01

Why it matters

Traders can reassess valuation and positioning based on the explicit FQ4 revenue range and next-quarter adjusted diluted EPS range, alongside the AI revenue mix improvement.

02

Market read

Earnings/guidance datapoints (loss, impairment, and forward ranges) dominate the trading setup; AI revenue mix growth is the main offset.

03

What to watch

The article highlights impairment and deferred tax charges but provides limited detail on cash flow, backlog, or margin trajectory—key drivers for whether guidance is a temporary trough.

Relevance 7/10Novelty 6/10Timing: post-FQ3 results with FQ4 revenue and next-quarter adjusted EPS guidance

Background

Endava’s FQ3 2026 update included revenue decline, impairment-related charges, and a strategic pivot toward AI-native delivery.

Company-level read

Ticker impact

$DAVABearishMedium confidence
Context

Endava reported FQ3 2026 revenue down 8.4% YoY and a £364.6M goodwill impairment, plus guided FQ4 revenue and EPS ranges.

Expected impact

Near-term downside bias as guidance implies continued YoY revenue decline and EPS weakness, partially offset by rising AI-native revenue share.

Evidence & confidence

The text includes specific quarterly results and forward ranges (revenue £181.0–£185.0M; adjusted diluted EPS £0.09–£0.13) plus large impairment/loss figures, which typically drive trading around earnings/guidance.

Market effects

Signals ongoing pressure in digital transformation/IT services demand cycles, while AI-native delivery is being positioned as a partial growth offset.

Primarily impacts UK-headquartered tech services sentiment and UK-listed investor perception of AI services monetization.

Read-across for global IT services peers on deal-cycle length and AI-driven revenue mix transition.

Counterpoint

AI-native revenue share rising from 5% to 15% could eventually stabilize growth even if near-term revenue and EPS remain weak.

Key entities

  • Endava

    Reported FQ3 2026 results with revenue down 8.4% YoY, £364.6M goodwill impairment, and provided FQ4 revenue and next-quarter adjusted EPS guidance.

  • Mastercard

    Named as a new partnership supporting Endava’s AI-driven business growth.

  • NatWest

    Named as part of a partnership (via Tyl) supporting Endava’s AI-driven business growth.

Related articles

$PLBLMed

Polibeli Group Ltd (PLBL): Financial results for H1 2026

Polibeli Group Ltd (PLBL) furnished an SEC Form 6-K — earnings release. Polibeli Group Ltd Announces Unaudited Financial Results for the six months ended June 30, 2026 On September 21, 2026, Polibeli Group Ltd (the “Company”) announced its unaudited financial results for the six months ended June 30, 2026. Business and Strategic Update ● As of the da

$VICRHighAI 8/10

Why is Vicor stock surging today?

Vicor Corporation's stock rose 12.3% after hours after raising its Q3 2026 revenue growth guidance from nearly 10% to over 20%, driven by royalties from its VPD licensing program. Four major companies have licensed the technology, and the CEO noted potential supply disruptions for unlicensed suppliers. The company also recently authorized a $150M share buyback and acquired properties for AI-driven demand. The Nasdaq closed at a record high, led by AI stocks, but broader indices were unchanged.

$OPTULow

Optimum Communications, Inc. (OPTU): Results of Operations and Financial Condition

Optimum Communications, Inc. (OPTU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Item 2.02 Results of Operations and Financial Condition. The information appearing below under Item 4.02 regarding certain previously reported financial information of Optimum Communications, Inc. (the "Company") for the fiscal year ended December 31, 2025, and the fiscal quarter

$ABVXMedAI 8/10

EQS-News: ABIVAX: Abivax Presents Business Updates and First Half 2026 Financial Results

Abivax reported H1 2026 financials with €402.4M in cash and €767.1M from a July offering, extending runway to Q4 2029. Leadership changes include Chris Rabbat as CMO and Tim Kelly as CTO. The company repurchased royalty certificates for €76.5M, reducing debt. R&D expenses rose 38.5% YoY to €107.9M, driven by clinical trial progress and new indications for obefazimod.